Related Party Transactions (Tables)

12 Months Ended

Dec. 31, 2018

Related Party Transactions [Abstract]

Schedule of Related Party Transactions

In the aggregate, BioTime charged Use Fees to OncoCyte and AgeX as follows (in thousands):

	Year Ended December 31,
	2018		2017
Research and development	$	1,378	$	1,085
General and administrative		790		557
Total use fees	$	2,168	$	1,642